quinazolines has been researched along with mevalonic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mothes, K | 1 |
| Dimitroulakos, J; Goss, G; Hanson, JE; Lagarde, AE; Lorimer, IA; Mantha, AJ | 1 |
| Bishop, KS; Denny, WA; Ferguson, LR; Lin, Z; Marlow, G; Murray, P; Sutherland, H | 1 |
3 other study(ies) available for quinazolines and mevalonic acid
| Article | Year |
|---|---|
[Alkaloids in the metabolism of plants].
Topics: Alkaloids; Dopamine; Indoles; Isoquinolines; Mevalonic Acid; ortho-Aminobenzoates; Papaver; Penicillium; Phenylalanine; Pipecolic Acids; Plants, Medicinal; Pregnenolone; Quinazolines; Sparteine; Terpenes; Tryptophan; Tyrosine | 1969 |
Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.
Topics: Adenosine Triphosphate; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Binding Sites; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Colonic Neoplasms; Drug Synergism; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gefitinib; Humans; Lovastatin; Lung Neoplasms; Mevalonic Acid; Mitogen-Activated Protein Kinases; Mutation; Phosphorylation; Quinazolines; Signal Transduction; Tumor Cells, Cultured | 2005 |
A quinazoline-based HDAC inhibitor affects gene expression pathways involved in cholesterol biosynthesis and mevalonate in prostate cancer cells.
Topics: Cell Line, Tumor; Cholesterol; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Inhibitory Concentration 50; Male; Mevalonic Acid; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Quinazolines; Reproducibility of Results; Signal Transduction | 2016 |